Serum and Peritoneal Fluid Immunological Markers in Adolescent Girls With Chronic Pelvic Pain

Agnieszka Drosdzol-Cop, Agnieszka Drosdzol–Cop, Drosdzol-Cop A, Violetta Skrzypulec‐Plinta, Skrzypulec-Plinta V, Violetta Skrzypulec-Plinta, Rafał Stojko, Stojko R
Obstetrical & gynecological survey · 2012 · vol. 67(6) , pp. 374–381 · doi:10.1097/ogx.0b013e31825cb12b · PMID:22713164 · W1979868320
article OA: closed CC0 ⤵ 33 in-corpus citations
View on OpenAlex View on PubMed View at publisher
⚙ AI-generated summary by claude@2026-06, 2026-06-09 ⓘ

Serum IL-4, peritoneal fluid IL-2, and peritoneal fluid IL-4 levels were higher in adolescent girls with endometriosis compared to controls, showing diagnostic potential.

One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works

Abstract

The aim of this study was to determine serum and peritoneal interleukin (IL)-2, IL-4, and monocyte chemotactic protein-1 levels as diagnostic markers of endometriosis in adolescent girls. The design of the study encompassed 50 adolescent girls, aged 13 to 19 years after menarche, with chronic pelvic pain who qualified for diagnostic laparoscopy. The patients were allocated into 2 groups: group I (endometriosis) consisted of subjects with diagnosed endometriosis (n = 33, 66%) and group II (control) whose laparoscopic examinations revealed no evidence of endometriosis (n = 17, 34%). IL-2, IL-4, and Monocyte chemotactic protein 1 concentrations in serum and peritoneal samples were assessed using commercially available human enzyme-linked immunosorbent assay kits. The results were analyzed statistically with the Statistica 8.0 computer software. The value of P < 0.05 was the level of statistical significance. The results in adolescents with endometriosis had significantly higher concentrations of serum IL-4 (3.90 ± 1.58 pg/mL vs. 3.04 ± 1.72 pg/mL; P = 0.04) and peritoneal fluid IL-4 (5.03 ± 8.92 pg/mL vs. 2.74 ± 1.11 pg/mL; P = 0.03), and lower peritoneal fluid IL-2 (92.44 ± 292.75 pg/mL vs. 174.23 ± 389.77 pg/mL; P = 0.01) compared with the control. In a receiver-operating characteristic analysis, serum IL-4 as well as peritoneal fluid IL-2 and IL-4 provided the best discriminative ability between subjects with endometriosis and controls. Using cutoff points for serum IL-4 (3.00 pg/mL), peritoneal fluid IL-2 (21.00 pg/mL) and IL-4 (2.7 pg/mL), relatively high odd ratios were obtained in the prediction of endometriosis in adolescents (3.2; 6.4; 3.3). The Serum IL-4, peritoneal IL-2 and IL-4 provided a good method of discrimination between subjects with endometriosis and controls. Target Audience: Obstetricians & Gynecologists, Family Physicians Learning Objectives: After completion of this educational activity, the reader will be able to Analyze the prevalence and clinical presentation of endometriosis in adolescents, which is significantly different from typical symptomatology observed in adult women. Assess the role of serum and peritoneal fluid IL-2, IL-4, and MCP-1 levels as diagnostic markers of endometriosis in adolescent girls. Use the cutoff value of serum IL-4 as well as peritoneal fluid IL-2 and IL-4 levels as the discrimination method between subjects with endometriosis and controls.

My notes (saved in your browser only)

Condition tags

endometriosischronic_pelvic_pain

MeSH descriptors

Chemokine CCL2 Endometriosis Endometriosis Interleukin-2 Interleukin-4 Pelvic Pain Adolescent Ascitic Fluid Ascitic Fluid Biomarkers Chemokine CCL2 Chronic Pain Endometriosis Endometriosis Endometriosis Enzyme-Linked Immunosorbent Assay Female Humans Interleukin-2 Interleukin-4

Citation neighborhood

Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.

References (23)

Cited by (34)

Source provenance

europepmc
last seen: 2026-08-09T06:10:49.860119+00:00
openalex
last seen: 2026-06-10T17:14:06.276822+00:00
pubmed
last seen: 2026-05-13T22:16:11.197438+00:00
unpaywall
last seen: 2026-06-13T06:42:57.164913+00:00
License: CC0 · commercial use OK